vTv Therapeutics (VTVT) Receivables - Net (2015 - 2024)

vTv Therapeutics has disclosed Receivables - Net across 10 years of filings, most recently posting $62000.0 for Q4 2024.

• In Q4 2024, Receivables - Net fell 39.22% year-over-year to $62000.0; the TTM figure through Dec 2024 stood at $62000.0 (down 39.22% YoY), while the FY2024 annual figure was $62000.0, down 39.22% from the prior year.
• Receivables - Net came in at $62000.0 for Q4 2024 at vTv Therapeutics, down from $242000.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $12.5 million in Q2 2022 to a low of $2000.0 in Q1 2021.
• Average Receivables - Net over 5 years is $3.1 million, with a median of $173000.0 recorded in 2022.
• Year-over-year, Receivables - Net jumped 21829.82% in 2023 and plunged 97.55% in 2024.
• Over 5 years, Receivables - Net stood at $158000.0 in 2020, then sank by 63.92% to $57000.0 in 2021, then surged by 203.51% to $173000.0 in 2022, then slumped by 41.04% to $102000.0 in 2023, then tumbled by 39.22% to $62000.0 in 2024.
• Per Business Quant data, the three most recent Receivables - Net figures were $62000.0 in Q4 2024, $242000.0 in Q3 2024, and $306000.0 in Q2 2024.